| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Teva Pharmaceutical Industries Ltd (TEVA) has 22 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. TEVA is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 426.3K | $15.23M | - | |
| CFO | 403.3K | $14.41M | - | |
| Dir | 367.6K | $13.13M | - | |
| VP | 148.8K | $5.32M | - | |
| Dir | 115.7K | $4.13M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 1, 2025 | Hughes Eric A | See "remarks" | Sale+OE | 52,742 | $15.16 | $799,436.87 | -100% | +30.2% | - | |
| Aug 1, 2025 | Jover Placid | See "remarks" | Sale+OE | 6,053 | $15.16 | $91,748.35 | -47.2% | +30.2% | - | |
| Jun 12, 2025 | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | Sell | 55,775 | $17.08 | $952,464.10 | -12.1% | +10.5% | - | |
| Jun 3, 2025 | Shields Matthew | EVP, Global Operations | Sale+OE | 6,206 | $17.02 | $105,627.98 | -38.3% | +9.1% | - | |
| May 8, 2025 | Sabag Mark | See "remarks" | Sell | 337,915 | $18.04 | $6,097,304.47 | -69.1% | -11.4% | - | |
| Mar 5, 2025 | Daniell Richard | Exec. VP, European Commercial | Sale+OE | 70,961 | $15.91 | $1,128,642.09 | -32.8% | +8.1% | +99.7% | |
| Mar 5, 2025 | Fox Christine | EVP, Head Of U.s. Commercial | Sale+OE | 6,181 | $15.80 | $97,639.02 | -4.9% | +8.1% | +99.7% | |
| Mar 5, 2025 | McAvoy David R. | EVP, Chief Legal Officer | Sale+OE | 4,827 | $15.80 | $76,250.43 | -15.9% | +8.1% | +99.7% | |
| Mar 5, 2025 | Hughes Eric A | See "remarks" | Sale+OE | 23,251 | $15.80 | $367,287.74 | -74.2% | +8.1% | +99.7% | |
| Mar 5, 2025 | Daniell Richard | Exec. VP, European Commercial | Sale+OE | 140,372 | $15.80 | $2,217,406.52 | -36.7% | +8.1% | +99.7% |